Sharfstein Optimistic On Prospects For Generic Drug User Fees
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency needs the new funding to tackle backlog of 1,300 ANDAs, acting commissioner tells House appropriations panel.
You may also be interested in...
Sharfstein Pledges FDA Spending Will Generate Public Health Value
The FDA under Margaret Hamburg and Joshua Sharfstein will be a proactive, results-oriented public health agency, Sharfstein indicated to congressional appropriations panels May 21
Sharfstein Pledges FDA Spending Will Generate Public Health Value
The FDA under Margaret Hamburg and Joshua Sharfstein will be a proactive, results-oriented public health agency, Sharfstein indicated to congressional appropriations panels May 21
Generic Drug Fees In, DTC Fees Dropped, From Obama Budget Proposal
Some of FDA's funding increase promised in President Obama's budget comes from user fees which would have to be established legislatively - meaning that the administration will have to negotiate with industry and congressional authorizing committees, not just House and Senate appropriators, in order to see its vision enacted